Bronchiolitis remains one of the most frustrating conditions in pediatric medicine precisely because so little actually works. Standard care guidelines have systematically rejected intervention after intervention, leaving clinicians with supportive care alone. A well-powered randomized trial now tests whether repositioning infants face-down — a maneuver with strong physiological rationale — can reduce the need for escalating respiratory support.
The PROPOSITIS trial enrolled 451 infants under six months of age receiving high-flow nasal cannula (HFNC) therapy for acute viral bronchiolitis between 2021 and 2023. The primary outcome — escalation to noninvasive or invasive positive pressure ventilation — favored prone positioning with an odds ratio of 0.66, but the 95% confidence interval crossed 1.0 (range 0.40–1.07), falling just short of statistical significance. Only three infants across the entire cohort required intubation, a lower-than-anticipated event rate that likely constrained the trial's statistical power.
The biological logic behind prone positioning is well-established in adult critical care: in ARDS patients, flipping to prone dramatically improves ventilation-perfusion matching and has become a cornerstone intervention backed by mortality data. In infants with bronchiolitis, lung mechanics differ substantially — airways obstruction rather than alveolar collapse is the dominant pathology — yet preliminary physiological work from the same group suggested measurable reductions in work of breathing in the prone position. The gap between physiological plausibility and clinical trial signal is a familiar story in bronchiolitis research. The near-significant odds ratio should not be dismissed outright; it may reflect genuine benefit obscured by an underpowered event rate rather than a null effect. What the trial does not resolve is whether continuous prone positioning is safe across all nursing contexts or whether specific subgroups — those with more severe baseline hypoxemia — capture disproportionate benefit. Replication with a composite outcome or adaptive design seems warranted before clinical practice shifts.